Li-Li Xu (Lili Xu)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Nlrp Inflammasome

Top Venues

Journal of medicinal chemistry

Oxidative medicine and cellular longevity

Analytical chemistry

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Bing-Yan Li, Pei Li, Lin-Yin Wei, Jia Zou, Yu-Hang Wang, Qi-Dong You, Cheng Jiang, Bin Di, Li-Li Xu
Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis. Journal of medicinal chemistry 67 (12) (2024)
Bing-Yan Li, Pei Li, Lin-Yin Wei, Jia Zou, Yu-Hang Wang, Qi-Dong You, Cheng Jiang, Bin Di, Li-Li Xu
Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis. Journal of medicinal chemistry 67 (12) (2024)
Bing-Yan Li, Pei Li, Lin-Yin Wei, Jia Zou, Yu-Hang Wang, Qi-Dong You, Cheng Jiang, Bin Di, Li-Li Xu
Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis. Journal of medicinal chemistry (2024)
Fan Yang, Zhen Dai, Ming-Yue Xue, Xiao-Yi Chen, Juan Liu, Li Wang, Li-Li Xu, Bin Di
Identification and Validation of PKR as a Direct Target for the Novel Sulfonamide-Substituted Tetrahydroquinoline Nonselective Inhibitor of the NLRP3 Inflammasome. Journal of medicinal chemistry 67 (12) (2024)
Fan Yang, Zhen Dai, Ming-Yue Xue, Xiao-Yi Chen, Juan Liu, Li Wang, Li-Li Xu, Bin Di
Identification and Validation of PKR as a Direct Target for the Novel Sulfonamide-Substituted Tetrahydroquinoline Nonselective Inhibitor of the NLRP3 Inflammasome. Journal of medicinal chemistry 67 (12) (2024)
Fan Yang, Zhen Dai, Ming-Yue Xue, Xiao-Yi Chen, Juan Liu, Li Wang, Li-Li Xu, Bin Di
Identification and Validation of PKR as a Direct Target for the Novel Sulfonamide-Substituted Tetrahydroquinoline Nonselective Inhibitor of the NLRP3 Inflammasome. Journal of medicinal chemistry (2024)
Yu-Hang Wang, Meng-Ze Zhou, Tao Ye, Ping-Ping Wang, Ran Lu, Yi-Lin Wang, Chun-Xiao Liu, Wen Xiao, Jia-Yi Li, Zi-Bo Meng, Li-Li Xu, Qing-Hua Hu, Cheng Jiang
Discovery of a Series of 5-Amide-1 H -pyrazole-3-carboxyl Derivatives as Potent P2Y 14 R Antagonists with Anti-Inflammatory Characters. Journal of medicinal chemistry 65 (23) (2022)
Zhen Dai, Lu-Yan An, Xiao-Yi Chen, Fan Yang, Ni Zhao, Cui-Cui Li, Ren Ren, Bing-Yan Li, Wei-Yan Tao, Pei Li, Cheng Jiang, Fang Yan, Zheng-Yu Jiang, Qi-Dong You, Bin Di, Li-Li Xu
Target Fishing Reveals a Novel Mechanism of 1,2,4-Oxadiazole Derivatives Targeting Rpn6, a Subunit of 26S Proteasome. Journal of medicinal chemistry 65 (6) (2022)
Lu-Yan An, Zhen Dai, Bin Di, Li-Li Xu
Advances in Cryochemistry: Mechanisms, Reactions and Applications. Molecules (Basel, Switzerland) 26 (3) (2021)
Zhen Dai, Xiao-Yi Chen, Lu-Yan An, Cui-Cui Li, Ni Zhao, Fan Yang, Song-Tao You, Chen-Zhi Hou, Kan Li, Cheng Jiang, Qi-Dong You, Bin Di, Li-Li Xu
Development of Novel Tetrahydroquinoline Inhibitors of NLRP3 Inflammasome for Potential Treatment of DSS-Induced Mouse Colitis. Journal of medicinal chemistry 64 (1) (2020)
Jing Jia, Huilin Wen, Sibo Zhao, Lancheng Wang, Haishi Qiao, Haowen Shen, Ziyi Yu, Bin Di, Li-Li Xu, Chi Hu
Displacement Induced Off-On Fluorescent Biosensor Targeting IDO1 Activity in Live Cells. Analytical chemistry 91 (23) (2019)
Li-Li Xu, Tian Liu, Lei Wang, Li Li, Yu-Feng Wu, Cui-Cui Li, Bin Di, Qi-Dong You, Zheng-Yu Jiang
Corrigendum to "3-(1H-Benzo[d]imidazol-6-yl)-5-(4-fluorophenyl)-1, 2, 4-oxadiazole (DDO7232), a Novel Potent Nrf2/ARE Inducer, Ameliorates DSS-Induced Murine Colitis and Protects NCM460 Cells against Oxidative Stress via ERK1/2 Phosphorylation". Oxidative medicine and cellular longevity 2018 (2018)